Continuous Glucose Monitoring Systems Market Revenue Is Expected To Reach Us$ 788.4 Mn By 2020
Future Market Insights (FMI) announces the release of its latest report titled, “Continuous Glucose Monitoring Systems Market: Global Industry Analysis and Opportunity Assessment 2015 - 2020”. According to the report, the global continuous glucose monitoring systems market was valued at US$ 402.0 Mn in 2014 and is expected to reach US$ 788.4 Mn by 2020, registering a CAGR of 12.1% during the forecast period, 2015 to 2020. Global continuous glucose monitoring systems market is driven by increasing number of diabetic patients and growing number of geriatric people across the world. Moreover, usage of advanced technologies such as artificial pancreas in continuous glucose monitors and increasing awareness of people towards diabetes are driving growth of the continuous glucose monitoring systems market. However, high prices of continuous glucose monitors and inadequate reimbursement policies pose a challenge for growth of the global continuous glucose monitoring systems market. The global continuous glucose monitoring systems market is segmented on the basis of end use sector, components and geography. Moreover, company wise market share has also been indicated in the report. By end use sector, global continuous glucose monitoring systems market is sub-segmented into household and hospital & diagnostic centers. Household is a larger segment as compared to hospital & diagnostic centers and is expected to dominate the continuous glucose monitoring systems market throughout the forecast period exhibiting a CAGR of 11.9%. The household segment held 68.5% market share in 2014 and expected to account for US$ 538 Mn by 2020, owing to the convenience and ease of use offered by continuous glucose monitors at home. Hospitals & diagnostic centers sub-segment accounted for approxim Continue reading >>
Global Continuous Glucose Monitoring (cgm) Market, By Product Type (transmitters And Receivers, Insulin Pumps, Sensors), By Application (diabetic Patients, And Diabetes Critical Care Patients), And By Geography - Trends And Forecast To 2024
Continuous Glucose Monitoring – Live an Uninterrupted Life Diabetes is a major global concern that, as per International Diabetes Federation (IDF) data, affected around 415 million people in 2015. Effective management of diabetes is vital, especially considering the sedentary lifestyle that most people across the globe have taken up. Continuous glucose monitoring (CGM) systems offer effective solution in diabetes management through continuous real-time glucose monitoring. Increasing awareness, supporting safety evidences for CGM systems and growing demand for point-of-care (POC) devices are major factors driving demand across the globe. However, high prices of these systems and the rather cumbersome experience of wearing of these relatively obtrusive gadgets throughout the day is currently restraining its demand in the low and middle income countries, where there is inadequate penetration of healthcare IT products and services. The global continuous glucose monitoring market was valued at US$ 2,035.8 million in 2015 and is expected to expand at a CAGR of 24.5% during the period 2016 – 2024. Figure 1. Global CGM Market Size and Forecast, US$ Million and Y-o-Y Growth (%) Sensors to emerge as highest revenue contributor among component segments Sensors are an integral part of CGM system. The type and sensitivity of the sensor are crucial factors that influence accuracy of sensing glucose level in the interstitial fluid. Although, transmitters hold a dominant share, accounting for over 50% (2015) share of the market, revenue contribution of the sensors segment is expected to increase at a faster growth rate during the forecast period (2016 – 2024). Rapid increase in demand for CGM devices, especially in emerging economies, is mainly attributed to increasing consumer a Continue reading >>
Global Continuous Glucose Monitoring System Market 2016-2022 - Medtronic And Dexcom Are The Only Major Players - Research And Markets
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Continuous Glucose Monitoring System Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022" report to their offering. Tweet this Emergence of continuous glucose monitoring systems is a major breakthrough in the glucose monitoring for diabetic patients. Medtronic and Dexcom are the only major players in this industry followed by Abbott in few regions. Companies are focusing more on research and development before introducing their products in the market. CGMS are highly regulated and go through strict tests before being approved. CGM manufacturers have faced competition from self-monitoring blood glucose devices (SMBG). SMBG devices are cheaper and easy to use and have an less stringent approval process from authorities like FDA. SMBG has more number of players and larger market share. However, CGM systems have been able to make a good market entry in the U.S. and are following the trend in other territories. CGM system market has seen good growth rates in past three years. Medtronic and Dexcom have introduced new systems which have witnessed lower frequency of errors. The MARD value for new sensors has decreased, new devices need lesser calibrations per day and most of the devices are approved for paediatric use. This has led to 50-60 percent jump in the revenues of some manufacturers. Companies profiled include 1. Medtronic Inc. 2. Dexcom 3. Abbott 4. Johnson And Johnson (Animas Corp) 5. Insulet Corp 6. Tandem Diabetes 7. Echo Therapeutics Key Topics Covered: 1. Executive Summary 2. Market Overview 2.1. What ARE CGMS? 2.2. Value Chain Analysis of the role of suppler, manufacturer, and end user in the CGMS market 2.2.1. Suppliers enabling financially weak play Continue reading >>
- Abbott's Revolutionary Continuous Glucose Monitoring System, FreeStyle Libre, Now Available To Medicare Patients - Jan 4, 2018
- Exercise and Glucose Metabolism in Persons with Diabetes Mellitus: Perspectives on the Role for Continuous Glucose Monitoring
- Continuous Versus Flash Glucose Monitoring To Reduce Hypoglycemia In Type 1 Diabetes
Continuous Glucose Monitoring Devices Market Companies: Medtronic, Johnson And Johnson, Insulet Corporation, Abbott Diagnostics
Continuous Glucose Monitoring Devices Market Report focuses on the major drivers and restraints for the key players. These Continuous Glucose Monitoring Devices Industry also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Continuous Glucose Monitoring Devices Market Research Report is a professional and in-depth study on the current state of Continuous Glucose Monitoring Devices. The global continuous glucose monitoring devices market was estimated to be around $0.5 billion as of 2016. The global continuous glucose monitoring devices made up around 2% of the overall diabetes care devices market in 2016. Browse More Detail Information About Continuous Glucose Monitoring Devices market report @ Key Players in Continuous Glucose Monitoring Devices Market Report: Medtronic Johnson and Johnson Insulet Corporation Abbott Diagnostics F. Hoffmann-La Roche AG Dexcom Inc. Senseonics Holdings The Continuous Glucose Monitoring Devices Market Report competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. And its key financial deals which have shaped the market in recent years are identified. Ask Sample PDF @ Scope of Continuous Glucose Monitoring Devices Market Report: Markets Covered: Insulin Pumps, Transmitters And Receivers, And Sensors. Companies Mentioned: Medtronic, Johnson and Johnson, Insulet Corporation, Abbott Diagnostics, F. Hoffmann-La Roche AG, Dexcom Inc., Senseonics Holdings, Inc., and GlySens Incorporated. Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia. Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Afr Continue reading >>
- Abbott's Revolutionary Continuous Glucose Monitoring System, FreeStyle Libre, Now Available To Medicare Patients - Jan 4, 2018
- Exercise and Glucose Metabolism in Persons with Diabetes Mellitus: Perspectives on the Role for Continuous Glucose Monitoring
- Johnson & Johnson’s new diabetes drug linked to coma and death
Continuous Glucose Monitoring Systems - A Growing Market
Summary Continuous glucose monitoring systems offer many advantages for diabetics opposed to “traditional” ways of measuring. Potential users are mostly type 1 diabetics that regularly use insulin, but the broader market also consists of type 2 diabetics that need insulin regularly. If insurance companies would cover the costs, it could be a massive catalyst for continuous glucose monitoring systems. If we assume all type 1 diabetics that use an insulin pump will also use a continuous glucose monitoring system, the market could be about $4 billion a year. Diabetes can be called a global pandemic - there are 415 million people affected by it worldwide right now and the number is expected to grow to 642 million in 2040. In 2015 one out of 11 adults had diabetes, in 2040 the number will be one out of 10. High blood sugar is the third highest risk factor for premature mortality, after high blood pressure and tobacco use. In 2015 about 5 million people died from diabetes. As diabetics are producing too little insulin or none at all (depending on the type of diabetes), the most important aspect when talking about diabetes is the constant availability of high quality insulin. The big names in this market are Sanofi (NYSE: SNY), Eli Lilly and Company (NYSE: LLY), Merck & Co Inc. (NYSE: MRK) and of course the diabetes giant Novo Nordisk (NYSE: NVO). But aside from the ability to administer insulin the diabetic has to be able to measure his or her blood sugar and in the last decade there have been some very interesting developments in this field. In this article, we talk about the future of blood sugar measurement and take a closer look at that market as well as a possible catalyst for continuous glucose monitoring systems. Why glucose measurement? The bodies of healthy peopl Continue reading >>
Cgm Devices Market Size To Reach $1.01 Billion By 2024
The continuous glucose monitoring (CGM) devices market is expected to reach USD 1.01 billion by 2024, according to a new report published by Grand View Research, Inc. The CGM devices market is anticipated to witness a lucrative growth during the period 2016 to 2024.The prevalence of diabetes is increasing worldwide and calls for the continuous monitoring of blood glucose levels. The traditional methods of blood glucose monitoring have been compromised by the advent of continuous glucose monitoring systems. These devices come with an innovative technology allowing quick and easy detection of blood glucose levels in the tissue fluid utilizing a small sensor for observation. By continuously observing readings at regular intervals, the continuous glucose monitoring systems allow patients to take adequate measures before hyperglycemic or hypoglycemic levels are reached. Factors that support the growth of CGM devices market are its benefits over the other blood glucose monitoring systems, early detection of glucose levels, an increase in the number of diabetics worldwide, and growing awareness among developing and under-developing countries about such devices. The restraints for CGM devices market are stringent regulatory impositions and expensive systems. One of the key opportunities for this market would be the approval of the artificial pancreas that would accelerate the application of CGM devices. The CGM devices industry, by product, is segmented into three types, transmitters and receivers, sensors, and insulin pumps. On the basis of end-user, the continuous glucose monitoring industry is categorized into hospitals, homecare diagnostics, research institutes, diagnostics, and clinical laboratories. To request a sample copy or view summary of this report, click the link b Continue reading >>
Amr: Continuous Glucose Monitoring Market To Hit $500m In 2020
The global market for continuous blood glucose monitoring is in for slow but steady growth, according to a new report from Allied Market Research. Though the relatively new market was valued at just $194.8 million in 2012, Allied projects it will hit $568.5 million by 2020, making for a compound annual growth rate of 14.8 percent between this year and 2020. "The market is overcoming several challenges towards the commercialization of closed loop CGMs with significant focus on technological innovation. This is expected to take the concept of CGM to a next level from research to mass adoption," AMR analyst Debbie Shields said in a statement. In continuous glucose monitoring, a patch or implanted sensor checks the glucose level in a user's interstitial fluid around every few minutes, sending the signals to a reading device via a transmitter. The technology has advantages over traditional blood glucose monitoring -- it's less invasive and can return data about blood glucose levels during sleep, or how glucose levels correspond to particular activities. For instance, DexCom continuous glucose monitors were used by cyclists in the mHealth Grand Prix this year. But adoption may have been limited by factors like issues with cost and accuracy and a lower level of reimbursement than traditional glucose monitoring technologies, Shields said. "However, the under commercialization is presenting opportunities for the marketers as new and innovative products will easily take the advantage of lower product presence, she said, adding that the impact of FDA's support for the artificial pancreas project and the continued increase in diabetes cases will contribute to the market's growth. Allied Research segmented the market in several ways. The firm found that home settings, as opposed to Continue reading >>
Innovations To Disrupt Blood Glucose Monitoring Market
Commonly Used Blood Glucose Monitoring Techniques Diabetes monitoring involves measuring and logging blood glucose levels, analyzing the information, and sharing it with care providers who provide personalized support to cope with the disease. According to Frost & Sullivan, the diabetes monitoring market is currently valued at $10.71 billion, and is forecasted to grow at a compound annual growth rate of 5.4% to reach $14.68 billion in 2022. This market consists of two major sub-segments: self-monitoring of blood glucose (SMBG) and continuous glucose monitoring (CGM). The finger-prick test, also called SMBG, is the most common technique used for measurement of blood glucose levels; however, it is painful and inconvenient, which could hinder regular testing and affect diabetes management. Another technique gaining wider acceptance is the CGM, in which a sensor linked to a CGM device is placed under a patient’s skin but not into the bloodstream. The sensor measures glucose levels in the interstitial fluid (ISF). Though it is less invasive than the finger-prick test, its accuracy is dependent on the equilibrium of glucose levels between ISF and blood, which accounts for a time delay in the measurement and hence requires frequent recalibration using the finger-pricking test. CGM does not replace the traditional SMBG technique as it also requires measurement of blood sugar with a regular glucose meter a few times a day. Moreover, sweat, temperature changes, and electrostatic noise can affect its accuracy. Technology Advancements Focus on Improving Patient Convenience and Becoming Integrated Devices Innovations in the glucose monitoring space are making devices smaller and more convenient. New semi-invasive, implant, and noninvasive approaches are being developed. Various av Continue reading >>
- 5 Stem Cell Innovations From The Past Year, From Cancer Treatment To Diabetes Therapy
- New diabetes treatment tops Cleveland Clinic's Top 10 Medical Innovations 2018 list (photos)
- Exercise and Glucose Metabolism in Persons with Diabetes Mellitus: Perspectives on the Role for Continuous Glucose Monitoring
Continuous Glucose Monitoring(cgm) Market Expected To Reach Usd 0.91 Billion Globally In 2019
Market report published by Transparency Market Research "Continuous Glucose Monitoring Market (Guardian Real Time, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo CGM Systems and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global continuous glucose monitoring market was valued at USD 0.37 billion in 2012 and is expected to grow at a CAGR of 13.6% from 2013 to 2019, to reach an estimated value of USD 0.91 billion in 2019. Browse Global Sterilization Equipment and Disinfectants Market Report with Full TOC at Continuous glucose monitoring systems (CGMS) are real time glucose monitoring devices that measure and display the glucose level of the interstitial fluid in the skin cells of the patient. These devices help patients manage diabetes (Type 1 and Type 2) in a more efficient manner. CGM devices typically comprise a sensor, transmitter and a receiver. The sensor is placed underneath the skin for monitoring glucose levels and is attached to the transmitter that relays the information to the monitor. Until recently, management of diabetes involved the use of conventional blood glucose meters that provided a single time snapshot of the patient's blood glucose level. However, demand for real time monitoring, minimally invasive and effective diabetes management solutions led to the advent of CGM devices. Rise in the incidence of diabetes globally coupled with increasing awareness of such devices that possess the ability to detect hyper and hypoglycemic events in real time will fuel the growth of this market during the forecast period. CGM is a rapidly evolving market supported by increasing adoption of these systems by hospitals and individual practitioners who further encourage their pa Continue reading >>
Continuous Glucose Monitoring (cgm) Devices Market Report, 2024
Industry Insights The continuous glucose monitoring devices market is estimated to account for USD 0.4 billion in 2016. One of the key factors supporting this industry’s growth is the escalating incidence of diabetes worldwide, which has accelerated the demand for these devices. The increasing number of diabetes mellitus cases in the world has triggered the manufacturers to bring about technological advancements in CGM devices, thus gaining leverage over traditional blood glucose monitoring devices. The other key drivers for the growth of this market are increasing the need for easy and efficient monitoring of blood glucose levels and the introduction of artificial pancreas. The advancement in technological innovations is the prime reason for the implementation of these devices, owing to which, the management and control of diabetes mellitus has become relatively easy. The early recognition of hyperglycemic and hypoglycemic levels is another factor that allows the usage of continuous glucose monitoring systems over the other blood glucose monitoring systems. The growing awareness among the people in the developing countries has also increased a demand for these devices. Chinese continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million) request a free sample copy The restraints that typically govern this industry are stringent regulatory norms, insufficient reimbursement options, and a high surge in the price and cost of treatment. There are tremendous opportunities for growth in this market as various companies have invested in the research and development of continuous glucose monitoring devices that would make the management and control of diabetes mellitus relatively easy. This is evident from the development of next generation disposable C Continue reading >>
Continuous Glucose Monitoring (cgm) Systems Market Is Expected To Reach $2,930 Million, Globally, By 2021 - Allied Market Research
According to a new report by Allied Market Research, titled, "World Continuous Glucose Monitoring (CGM) Systems - Market Opportunities and Forecasts, 2014 -2021", the global continuous glucose monitoring market would generate a revenue of $2,930 million by 2021, registering a CAGR of 31.3% during 2015-2021. CGM sensors accounted for about two-third share of the global CGM components market in 2014 and would continue to dominate the market until 2021. The need of active management and control of diabetes has grown considerably with growing number of diabetic population and associated cost burden. It is projected that, by 2035, the diabetes-affected patient population would reach 471 million with an associated cost burden of $627 billion. Continuous monitoring and managing glucose levels is an essential factor in diabetes management, which is primarily delivered by CGMs. In the progression, many high-tech variants of CGMs have evolved such as smartphone-connected CGMs, wearable CGMs and non-invasive CGMs. The improved efficacy and high disease prevalence has brought these devices to center stage to glucose monitoring. Increasing awareness, FDA approval to the novel and innovative products such as bionic pancreas and focus on developing CGM devices to serve new end user segment are prime drivers to the growth of CGM market. However, lack of adequate reimbursement regime for devices and clinicians, has been the key barrier to the adoption of the devices. To view the report, visit the website at Sensors led the market for CGM components and would also be the fastest growing segment. This growth is primarily supplemented by the recurring sales, high frequency of use, bulk purchasing and the limited life of sensors. Integrated insulin pumps would emerge as the lucrative market Continue reading >>
Continuous Glucose Monitoring (cgm) Market Will Reach $568.5 Million Globally By 2020 - Allied Market Research
According to the new market research report titled "Continuous Glucose Monitoring Market (CGM Systems, Application, Diabetic Type, and Adoption by Age Group) - Current Trends, Size, Share, Industry Analysis, Competitive Intelligence, Growth, Opportunities and Global Forecasts, 2012 - 2020" by Allied Market Research, the global continuous glucose monitoring (CGM) market is projected to reach $568.5 million by 2020 from 2012 value of $194.8 million growing at a CAGR of 14.8% during 2013 - 2020. The major factors driving the market growth are convenience offered by CGM over conventional glucose monitoring devices, earlier detection of the hypo and hyperglycemic events, rise in incidences of diabetes cases globally, and awareness among global population. The complete report is available at "The market is overcoming several challenges towards the commercialization of closed loop CGMs with significant focus on technological innovation. This is expected to take the concept of CGM to a next level from research to mass adoption" noted AMR analyst Debbie Shields. Despite such encouraging innovations, commercialization has not reached to desired levels. Major factors responsible for this are issues related with accuracy as well as cost, less attractive reimbursement coverage, and strict regulatory impositions. "However, the under commercialization is presenting opportunities for the marketers as new and innovative products will easily take the advantage of lower product presence" Debbie explains. The impact of FDA approval for artificial pancreas, superiority of CGMs over self-monitoring devices and rise in diabetes cases will have significant impact on the overall market growth. Browse all medical devices research reports by Allied Market Research at The market is categorized int Continue reading >>
Continuous Glucose Monitoring Systems Market, 2022: Global Market Expected To Grow At Cagr Of 24.10% - Research And Markets
The global CGM Systems market is expected to grow at a CAGR of 24.10% from 2016 to 2022 and reach a figure of $2.13 billion by 2022. The advancements in technology, ease of use, smart device connectivity are some of the major driving factors for this market. The global CGM Systems market has been classified on the basis of component, end user group, application and geography. Sensors generated the maximum revenue at an estimated CAGR of 24.60% from 2016 to 2022. The durability of sensors, its affordable cost, and miniaturization are factors supporting the market growth. The integration of insulin pumps in CGM systems and emerging artificial pancreas technology exhibits insulin pumps as the fastest growing segment at a CAGR of 24.80% during the forecast period. The installment of a transmitter and a receiver is a onetime process and hence the cost incurred is very low which results in low market value. Diabetes affects all age groups and hence the need for CGM Systems are increasing with the growing awareness and adoption of the device. The end user group is divided on the basis of patient's age and their complications. In this report the end user group are categorized as Children & Teens, Youth, and Middle Aged & Aged. The end applications of the CGM systems can be seen in Home, Hospitals, Clinics, and Diagnostics Centers. Household or Home setting application have dominated the market in 2015 and growing at a CAGR of 24.70% from 2016 to 2022. North America dominated the global market in 2015 with a share of 46% due to the increasing adoption of CGM devices for better healthcare management. APAC, holds the highest number of diabetic patients where a large number of developments in diabetic care have been noticed in the last few years. However, the APAC is estimated to s Continue reading >>
Global Continuous Glucose Monitoring Market To Rise At 13.60% Cagr Till 2019, Propelled By Rise In Diabetic Population
Transparency Market Research has published a new report on the global continuous glucose monitoring market. According to the report, the global continuous glucose monitoring market was valued at US$370 mn in 2012 and is predicted to reach US$910 mn by 2019. The report, titled ‘Continuous Glucose Monitoring Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019’, states that the global continuous glucose monitoring market is predicted to expand at a 13.60% CAGR during the period from 2013 to 2019. Browse the full Continuous Glucose Monitoring Market (Guardian Real Time, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo CGM Systems and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 report at The demand for continuous glucose monitoring systems (CGMS) has increased rapidly as these systems display real-time glucose levels from the patient’s body at regular intervals. CGMS use wireless technology to measure glucose levels. As per the International Diabetes Federation (IDF), globally, about 382 mn people were identified with diabetes in 2013 and the number is predicted to reach 592 mn by 2035. The increasing number of people being diagnosed with diabetes is expected to propel the global continuous glucose monitoring market throughout the forecast period. The global continuous glucose monitoring market is segmented on the basis of geography and device/brand. By device/brand, the global continuous glucose monitoring market is classified into guardian real time CGM system, freestyle navigator, dexcom seven plus CGM system, dexcom G4 platinum, minimed paradigm revel/veo system, and others. Based on device/brand, the global continuous glucose monitoring market i Continue reading >>
Continuous Glucose Monitoring Devices Market - Global Industry Insights, Trends, Outlook, And Opportunity Analysis, 2016 - 2025
LAS VEGAS, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Global Continuous Glucose Monitoring (CGM) Devices are used to monitor glucose level throughout day and night. A sensor is placed under the skin which measures the glucose level in tissue fluid. A transmitter is connected to the sensor which transfers information via wireless radio frequency. This transmitter is connected to monitoring and display device. These devices are used to monitor blood glucose level of diabetic patients. Diabetes is a chronic disease which is classified into type 1 and type 2. Diabetes occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin. The symptoms of diabetes are frequent urination, blurred vision, increased thirst, rapid weight loss, numbness or tingling sensation in hands or feet and increased hunger. Factors which increase the risk of diabetes are ethnicity, family history of diabetes, and physical inactivity. The exact causes of type 1 diabetes are unknown. Type 1 diabetes can be caused due to complex interaction between genes and environmental factors. The strongest risk factors for type 2 diabetes are overweight and obesity. Diabetes can damage the heart, eyes, blood vessels, kidneys, and nerves which may lead to disability and premature death. People with diabetes are likely to incur disastrous personal health expenditure. According to a study conducted by American Diabetes Association, 415 million people worldwide suffered from diabetes and diabetes related complications as of 2015, and this number is expected to reach 642 million by 2040. Over the past three decades, the predominance of diabetes is increasing, but it is growing at a higher rate in low and middle income countries. As per International Diabetes Federation, abou Continue reading >>
